Complex pathological fracture and severe bone disease as a presenting manifestation of multiple myeloma: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20232135Keywords:
Plasma cell dycrasia, Multiple myeloma, Pathological fracture, Punched-out lesionAbstract
Multiple myeloma is a clonal plasma cell disorder that commonly affect bones, leading to characteristic bone findings on imaging studies. Here, we present the case of a male patient in his late-forties who presented with back pain and was found to have lytic lesions in skull and pelvis on X-ray. Further workup confirmed the diagnosis of Multiple myeloma and the patient was started on chemotherapy and denosumab. This case highlights the importance of early recognition of characteristic bone findings on imaging studies and conducting a thorough workup in patients with suspected multiple myeloma.
References
Rajkumar SV. Multiple myeloma: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022;97(8):1086-107.
Dimopoulos MA, Moreau P, Terpos E. Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2022;33(1):117.
Anderson KC, Carrasco RD. Pathogenesis of myeloma. Annu Rev Pathol. 2011;6:249-274.
Smith D, Yong K. Multiplemyeloma. BMJ. 2013;34-6:f3863.
Kariyawasan CC, Hughes DA, Jayatillake MM, Mehta AB. Multiple myeloma: causes and consequences of delay in diagnosis. QJM. 2007;100(10):635-40.
Healy CF, Murray JG, Eustace SJ, Madewell J, O'Gorman PJ, O'Sullivan P. Multiple myeloma: a review of imaging features and radiological techniques. Bone Marrow Res. 2011;2011:583439.
Durie BGM, Hoering A, Abidi MH. Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial. Lancet (London, England). 2017;389(10068):519-27.
